SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10247)5/11/2018 12:35:41 PM
From: mattstat  Read Replies (1) | Respond to of 12873
 
The way things are going, pretty soon some of us may be able to buy the company.



To: HardToFind who wrote (10247)5/11/2018 4:34:54 PM
From: donpat  Read Replies (1) | Respond to of 12873
 
Getting the foot in the door is the stage we (NNVC)/Theracour) is in NOW!!

What's that worth to Glaxo or any entity that believes as Boniuk, Brandt, Myers, Me, St Jude's Webster and SUNY's Moffat do?

PLENTY!

I'd offer the well researched opinion honed over an intense study these last 82 years mostly in the IP business that the coming financing hinges on that "PLENTY".


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News